or Try an Advanced Search...

    Technical Analysis for CRGX - CARGO Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 16.23 3.18% 0.50
    CRGX closed up 3.18 percent on Friday, November 22, 2024, on 57 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CRGX trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness 3.18%
    Inside Day Range Contraction 3.18%
    Wide Bands Range Expansion 3.18%
    Oversold Stochastic Weakness 3.18%
    Lower Bollinger Band Walk Weakness 2.59%
    Outside Day Range Expansion 2.59%
    Wide Bands Range Expansion 2.59%
    Older End-of-Day Signals for CRGX ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 14 hours ago
    60 Minute Opening Range Breakout about 16 hours ago
    Rose Above Previous Day's High about 16 hours ago
    Up 3% about 16 hours ago
    Up 2% about 16 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CRGX Chart by TradingView
    Basic chart:

    Profile

    CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Immune System Tumor Cancer Immunotherapy Gene Therapy Therapies For Cancer T Cells Antigen Cd22 Car T Cell Siglec

    Is CRGX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 CARGO Therapeutics GAAP EPS of -$0.88
    Nov 12 CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
    Oct 18 Here's Why We're Not Too Worried About CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Situation
    Aug 16 Why Cargo Therapeutics Stock Rocketed Nearly 20% Higher This Week
    Jul 29 With 54% ownership of the shares, CARGO Therapeutics, Inc. (NASDAQ:CRGX) is heavily dominated by institutional owners
    Jul 10 CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
    Jun 4 CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
    Jun 4 $4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
    May 28 CARGO Therapeutics looks to raise $110M through equity financing
    May 28 CARGO Therapeutics to Participate in Upcoming Investor Conferences
    See more CRGX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 33.92
    52 Week Low 13.56
    Average Volume 284,273
    200-Day Moving Average 19.90
    50-Day Moving Average 19.99
    20-Day Moving Average 19.37
    10-Day Moving Average 17.51
    Average True Range 1.48
    RSI (14) 35.48
    ADX 24.83
    +DI 14.20
    -DI 29.16
    Chandelier Exit (Long, 3 ATRs) 18.56
    Chandelier Exit (Short, 3 ATRs) 19.71
    Upper Bollinger Bands 24.41
    Lower Bollinger Band 14.33
    Percent B (%b) 0.19
    BandWidth 52.00
    MACD Line -1.25
    MACD Signal Line -0.71
    MACD Histogram -0.5356
    Fundamentals Value
    Market Cap 668.76 Million
    Num Shares 41.2 Million
    EPS
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 18.08
    Resistance 3 (R3) 18.04 17.38 17.77
    Resistance 2 (R2) 17.38 16.91 17.40 17.66
    Resistance 1 (R1) 16.81 16.62 17.10 16.85 17.56
    Pivot Point 16.15 16.15 16.30 16.17 16.15
    Support 1 (S1) 15.58 15.68 15.87 15.62 14.90
    Support 2 (S2) 14.92 15.39 14.94 14.80
    Support 3 (S3) 14.35 14.92 14.69
    Support 4 (S4) 14.39